Pfizer (PFE) SVP Jennifer Damico granted stock awards and has shares withheld for taxes

Rhea-AI Filing Summary

Pfizer Inc. senior vice president and controller Jennifer B. Damico reported equity compensation activity and related tax withholding. On March 3, she received grants of Pfizer common stock totaling 21,719 shares in the form of restricted stock units, which are subject to vesting requirements, and 22,638 stock appreciation rights that will be settled in common shares on the fifth anniversary of the grant date.

On March 4, 826 shares of common stock were withheld to cover tax obligations when restricted stock units (and related dividend equivalents) vested. After these transactions, she directly held 32,934 Pfizer common shares.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider DAMICO JENNIFER B.

Role SVP & Controller

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	826	$26.62	$22K
Grant/Award	Stock Appreciation Rights	22,638	$0.00	--
Grant/Award	Common Stock	16,311	$0.00	--
Grant/Award	Common Stock	5,408	$0.00	--

Holdings After Transaction: Common Stock — 32,934 shares (Direct); Stock Appreciation Rights — 22,638 shares (Direct)

Footnotes (1)

1. The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAMICO JENNIFER B.

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NY 10001-2192

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Controller

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		16,311(1)	A	$0.0000	28,352	D
Common Stock	03/03/2026		A		5,408(1)	A	$0.0000	33,760	D
Common Stock	03/04/2026		F		826(2)	D	$26.62	32,934	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$26.58	03/03/2026		A		22,638		03/03/2031(3)	03/03/2031(3)	Common Stock	22,638	$0.0000	22,638	D

Explanation of Responses:

1. The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

2. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

3. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

	/s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Pfizer (PFE) report for Jennifer B. Damico?

Pfizer reported that Jennifer B. Damico received grants of restricted stock units and stock appreciation rights, and had shares withheld to satisfy tax obligations upon vesting. These transactions reflect routine equity compensation activity for a senior executive.

How many Pfizer (PFE) shares were granted to Jennifer B. Damico in this Form 4?

Jennifer B. Damico was granted 21,719 Pfizer common shares in the form of restricted stock units on March 3. These awards are subject to vesting requirements, meaning she earns the shares over time rather than immediately.

What stock appreciation rights did Jennifer B. Damico receive from Pfizer (PFE)?

She received 22,638 stock appreciation rights on March 3, which will be settled in Pfizer common stock on the fifth anniversary of the grant date. These rights are also subject to vesting conditions before settlement in shares.

Why were some Pfizer (PFE) shares disposed of in Jennifer B. Damico’s Form 4?

The disposition of 826 Pfizer common shares reflected shares withheld to cover tax obligations when restricted stock units and related dividend equivalents vested. This is a tax-withholding transaction, not an open-market sale of stock.

How many Pfizer (PFE) shares does Jennifer B. Damico hold after these transactions?

After the reported equity grants and tax-withholding event, Jennifer B. Damico directly held 32,934 shares of Pfizer common stock. This figure reflects her updated direct ownership following the March 3 and March 4 transactions.

Are Jennifer B. Damico’s Pfizer (PFE) equity awards immediately vested?

No. The filing notes that both the restricted stock units and the stock appreciation rights granted to Jennifer B. Damico are subject to vesting requirements. She will earn full ownership of these awards only as those conditions are satisfied.